Durvalumab,Carboplatin,Paclitaxel,Cisplatin,Gemcitabine,Pemetrexed,Atezolizumab,Bevacizumab
Astrazeneca,roche
[]
the #oncoalerttoptweet day 4 of #aacr23 tweet by the oncoalert newsletter is out daily
a great way to catch up on the scientific news from the meeting sign up at best, 
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨